Barclays’s Dorman Products DORM Stock Holding History

Barclays’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,900	Closed	-$1.19M	–	5334
2025 Q1	$1.19M	Buy	+9,900	New	+$1.26M	﹤0.01%	3003

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Barclays's DORM Position: Q1 2026 in Review

Barclays reduced its Dorman Products (DORM) stake by 88% in Q1 2026, selling an estimated $4.49M and leaving 5,337 shares worth $557K. The position accounts for ﹤0.01% of the portfolio, ranked #3135.

Barclays first reported a position in DORM in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.92M in Q2 2025. 318 funds tracked by Wall St. Rank hold DORM as of Q1 2026.

Barclays held 5,337 shares of Dorman Products worth $557K as of Q1 2026.
Barclays sold 37,727 Dorman Products shares in Q1 2026, an estimated $4.49M.
Dorman Products made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3135 holding.
Barclays first reported a position in Dorman Products in Q2 2013 and has held it in 51 quarters since.
Barclays's Dorman Products position peaked at $6.92M in Q2 2025.
318 funds tracked by Wall St. Rank held Dorman Products as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.